Pay in 4 interest-free payments of $5.37 Learn more
Ships within 48 hours · Estimated delivery Oct 2 - Oct 7
Among injectables, Roche's CT-388 (enicepatide) showed 22.5% weight loss in Phase 2 at 48 weeks with no plateau reached, and Amgen's MariTide reached 20% at 52 weeks in Phase 2
Last updated: April 3, 2026 If you have lost significant weight through GLP-1 medications like Ozempic, Wegovy, or Mounjaro, you are not alone in wondering what comes next
El tratamiento se inicia con la dosis ms baja durante el primer mes y, por lo general, se va aumentando hasta alcanzar la dosis ms alta al cabo de 5 meses
Glucose-dependent insulinotropic peptide-overexpressing transgenic mice have increased bone mass
US$ 20.23
US$ 25.40
US$ 24.12
US$ 20.75
US$ 23.67
US$ 28.29
US$ 24.30
US$ 27.34
